Table 2.
In vivo silver intake over 7-day study duration for ME dressing (negative control) and ROCF-ciNPT dressing
| Sample | Silver (μg/g) |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Standard of care (ME dressing) |
ROCF-ciNPT |
|||||||||
| Day 0 | Day 1 | Day 3 | Day 5 | Day 7 | Day 0 | Day 1 | Day 3 | Day 5 | Day 7 | |
| Feces | <0.2 | <0.2 | <0.2 | <0.2 | <0.2 | <0.2 | <0.2 | <0.2 | <0.2 | <0.2 |
| Urine | <0.04 | <0.04 | <0.04 | <0.04 | <0.04 | <0.04 | <0.04 | <0.04 | <0.04 | <0.04 |
| Blood | <0.04 | <0.04 | <0.04 | <0.04 | <0.04 | <0.04 | <0.04 | <0.04 | <0.04 | <0.04 |
| Kidney | <0.1 | <0.1 | <0.1 | <0.1 | <0.1 | <0.1 | <0.1 | <0.1 | <0.1 | <0.1 |
| Liver | <0.1 | <0.1 | <0.1 | <0.1 | <0.1 | <0.1 | <0.1 | <0.1 | <0.1 | <0.1 |